Transcranial Magnetic Stimulation (TMS) for Treatment of Auditory Hallucinations
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00763841 |
Recruitment Status
:
Completed
First Posted
: October 1, 2008
Last Update Posted
: January 20, 2010
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Auditory Hallucinations | Device: Transcranial magnetic stimulation Device: Sham | Phase 1 |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 18 participants |
Allocation: | Randomized |
Intervention Model: | Crossover Assignment |
Masking: | Double (Participant, Outcomes Assessor) |
Primary Purpose: | Treatment |
Official Title: | A Pilot Study Using Transcranial Magnetic Stimulation (TMS) to Investigate the Role of the Temporal Cortex in Schizophrenic Patients With Auditory Hallucinations |
Study Start Date : | September 1999 |
Actual Primary Completion Date : | September 2008 |
Actual Study Completion Date : | September 2008 |
Arm | Intervention/treatment |
---|---|
Experimental: 1
Stimulation will be given daily at a particular site for three days a week
|
Device: Transcranial magnetic stimulation
Stimulation will be given daily at a particular site for three days a week
|
Sham Comparator: 2 | Device: Sham |
- Daily Voices Ratings (Mental Health Research Institute, Victoria) [ Time Frame: Daily ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Over 18, with DSM-IV diagnosis of Schizophrenia and auditory hallucinations of clear external origins, refractory to pharmacotherapy and occurring at least 5 times per day.
Exclusion Criteria:
- Subjects with contraindications to TMS (e.g. epilepsy, pacemaker) or those with an unacceptably high risk (e.g. suicide risk) will be excluded from the study.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00763841
Australia, New South Wales | |
School of Psychiatry | |
Sydney, New South Wales, Australia, 2031 |
Principal Investigator: | Colleen Loo, MBBS, FRANZCP. MD | University of NSW |
Responsible Party: | Assoc. Prof. Colleen Loo, University of NSW |
ClinicalTrials.gov Identifier: | NCT00763841 History of Changes |
Other Study ID Numbers: |
07019 |
First Posted: | October 1, 2008 Key Record Dates |
Last Update Posted: | January 20, 2010 |
Last Verified: | November 2009 |
Keywords provided by The University of New South Wales:
Auditory hallucinations |
Additional relevant MeSH terms:
Hallucinations Perceptual Disorders Neurobehavioral Manifestations |
Neurologic Manifestations Nervous System Diseases Signs and Symptoms |